IOVA Operating Income Growth
Iovance Biotherapeutics Inc · Operating Income Growth
IOVA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported27.88%period ending
IOVA TTM Operating Income YoY % (72.40% → 27.88%)
Year-over-year change
High-resolution chart · PNG
IOVA operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 27.8764% | |
| 10.2167% | |
| -0.7425% | |
| 4.3327% | |
| 10.5859% | |
| 14.6864% | |
| 14.1743% | |
| 3.6701% | |
| -7.2087% | |
| -11.8185% | |
| -15.4636% | |
| -14.0636% | |
| -13.5804% | |
| -16.4904% | |
| -16.3917% | |
| -25.5106% | |
| -32.5692% | |
| -34.5519% | |
| -30.8341% | |
| -20.6021% | |
| -13.2737% | |
| -12.2009% | |
| -26.6179% | |
| -46.2964% | |
| -56.8228% | |
| -68.1411% | |
| -61.2936% | |
| -48.0115% | |
| -50.1411% | |
| -42.9798% | |
| -38.0945% | |
| -44.3097% | |
| -34.4031% | |
| -46.4532% | |
| -73.152% | |
| -79.0865% | |
| -127.6743% | |
| -128.2937% | |
| -92.5305% | |
| -90.5027% | |
| -79.6115% | |
| -96.1268% | |
| -131.3953% | |
| -29.8822% | |
| -4.4733% | |
| 13.8203% | |
| 24.4715% | |
| -202.7895% | |
| -265.3294% | |
| -206.8397% | |
| -96.0039% | |
| 41.8027% | |
| 65.5977% | |
| 75.9369% | |
| 61.6693% | |
| 39.5573% | |
| -24.3982% | |
| -1,585.7933% | |
| -2,502.4489% | |
| -5,349.6446% | |
| -7,414.3558% | |
| -1,729.2933% | |
| -5,069.3444% | |
| -1,058.4873% | |
| -490.7644% | |
| -99.8128% | |
| 72.3976% |